Indian Pharmaceutical Alliance slams US over charges on Indian patent lawIf a country feels that a provision or policy of another nation discriminates against its companies, it can challenge that under WTO's disp...
IP environment deteriorating in India: US pharma industryUS pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights are unr...
'US lawmakers ask India to embrace market-driven approaches'US lawmakers today alleged that India's "discriminatory" trade and industry policies were hurting American companies.
US lawmakers oppose India’s intellectual property regimeIndian policymakers and courts have taken a series of actions designed to block imports by forcing local production of manufactured goods.
Pfizer's slams India's patent regime, says Indian standards are vague and malleableUS drugmaker Pfizer has slammed the patent regime in India, telling that all patents that the company has managed to get in India do not ha...
BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drugA BDR Pharma executive said that the firm has applied to sell a generic version of BMS's patented anti-cancer drug Dasatanib at a much lowe...
India undermining intellectual property: PfizerPfizer said US lawmakers that New Delhi is undermining intellectual property by misuse of its compulsory licence provisions.